NKG2C Natural Killer Cells in Bronchoalveolar Lavage Are Associated With Cytomegalovirus Viremia and Poor Outcomes in Lung Allograft Recipients.

MLA

Calabrese, Daniel R., et al. “NKG2C Natural Killer Cells in Bronchoalveolar Lavage Are Associated With Cytomegalovirus Viremia and Poor Outcomes in Lung Allograft Recipients.” Transplantation, vol. 103, no. 3, Mar. 2019, pp. 493–501. EBSCOhost, https://doi.org/10.1097/TP.0000000000002450.

APA

Calabrese, D. R., Chong, T., Wang, A., Singer, J. P., Gottschall, M., Hays, S. R., Golden, J. A., Kukreja, J., Lanier, L. L., Tang, Q., & Greenland, J. R. (2019). NKG2C Natural Killer Cells in Bronchoalveolar Lavage Are Associated With Cytomegalovirus Viremia and Poor Outcomes in Lung Allograft Recipients. Transplantation, 103(3), 493–501. https://doi.org/10.1097/TP.0000000000002450

Chicago

Calabrese, Daniel R, Tiffany Chong, Angelia Wang, Jonathan P Singer, Marc Gottschall, Steven R Hays, Jeffrey A Golden, et al. 2019. “NKG2C Natural Killer Cells in Bronchoalveolar Lavage Are Associated With Cytomegalovirus Viremia and Poor Outcomes in Lung Allograft Recipients.” Transplantation 103 (3): 493–501. doi:10.1097/TP.0000000000002450.